Twice-daily dosing of Accolate provides sustained levels of antileukotriene protection, leading to sustained morning and evening airway funcion
In a 6-week placebo-controlled study in a mixed asthma population of whom 66% were receiving corticosteroid therapy, Accolate provided sustained improvements in the morning and evening peak expiratory flow rate
References
Miyamoto - as above |
